logging in or signing up 2011 Victorian CTTG Monash jakey39 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 32 Category: Education License: All Rights Reserved Like it (0) Dislike it (0) Added: August 27, 2011 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript ARPANSA MDCT Updates: ARPANSA MDCT Updates Anthony Wallace, Manager, Diagnostic Imaging & Nuclear Medicine Section, ARPANSA anthony.wallace@arpansa.gov.auTopics: Topics National, State & Territory regulatory environment ARPANSA NDRL survey Clinically useful dosimetry Recent propositions from Brenner Effective Dose applied to individuals Organ dose development necessity Radiation Dose Structured Reports Future developments eHealth and individual dose histories Radiation Oncology imaging RDSR as a national dose survey toolAustralian Regulatory Environment: Australian Regulatory EnvironmentRadiation Codes & Safety Guides: Radiation Codes & Safety Guides 4 NDRP RPS 6 Medical Code RPS 14 Safety Guides 2008 RPS 14.1 2008 RPS 14.2 2008 RPS 14.3 2004 2008 http://www.arpansa.gov.au/Publications/codes/rps.cfmDirect & Indirect Regulatory Drivers: Direct & Indirect Regulatory Drivers 5 ARPANSA Code of Practice Local Regulatory Requirements Medicare Practice Accreditation (DIAS)Codes & Safety Guides - DRLs: Codes & Safety Guides - DRLs 6 Diagnostic reference levels 3.1.8 The Responsible Person must establish a program to ensure that radiation doses administered to a patient for diagnostic purposes are: ( a) periodically compared with diagnostic reference levels ( DRLs) for diagnostic procedures for which DRLs have been established in Australia; and ( b) if DRLs are consistently exceeded, reviewed to determine whether radiation protection has been optimized .ARPANSA NDRL Survey: ARPANSA NDRL SurveyThe Rationale: The Rationale We want the data per scanned habitus You want a practice report per protocol You can use the report to assist in dose optimization To achieve this; Each protocol should be specific Don’t mix multiple phases, contrast with non-contrast, etc Dose modulation is problematic, mAs is indicativeSlide 9: www.arpansa.gov.au NDRL LinkPractice Registrations.....so far: Practice Registrations.....so far State/Territory Number ACT 4 NSW 7 NT 0 QLD 3 SA 0 TAS 0 VIC 5 WA 9Clinically Useful Dosimetry: Clinically Useful DosimetryThe Old, Tried & True Standards: The Old, Tried & True Standards CTDI Air , Weighted, Volume (mGy) DLP (mGy.cm) mSv/mGy.cm conversion tables If you don’t know what these are and how they are applied to patient dosimetry You should be having a serious look at yourselfThe Effective Dose Dilemma: The Effective Dose Dilemma California has recently legislated as mandatory that all CT patients must be told the effective dose of the procedure and its consequent risk for them The fact that effective dose is a statistical population risk construct and cannot be applied to the individual didn’t seem to carry much weight A knee jerk response to CT dose sensitivity Don’t think it couldn’t happen hereIf Not Effective Dose……..?: If Not Effective Dose……..? Effective dose is an inappropriate dose risk metric for the individual More accurate radiation risk assessments should be constructed from an organ dose assessment Individual radiosensitivities – normal distribution? Individual organ dose radiosensitivities Heterogeneous dose distributions Need a real time, platform embedded organ dose calculator for reasonable risk assessmentAge Dependent Dosimetry Risk: Age Dependent Dosimetry Risk Hall, Pediatric Radiology, (2002) Vol.32Prof. David Brenner Postulates: Prof. David Brenner Postulates Supports the increased radiosensitivities of paediatrics, but Proposes that there is an inverse relationship between age at exposure and expression of detriment An outcome of Bystander effectsBystander Effect: Bystander EffectAge related Cancer Mortality: Age related Cancer Mortality Cancer incidence still primarily expressed in late middle age and older but if exposed at younger age there will be an increased expression of detriment from those exposuresRadiation Dose Structured Reports: Radiation Dose Structured ReportsRadiation Dose Structured Report: Radiation Dose Structured ReportRDSR – General Use: RDSR – General UseRDSR – General Use: RDSR – General UseRDSR – Key Measurements: RDSR – Key MeasurementsRDSR – More Details: RDSR – More DetailsRDSR – Creating Reports: RDSR – Creating ReportsRDSR – Applications I: RDSR – Applications IRDSR – Applications 2: RDSR – Applications 2RDSR - Wrap-up: RDSR - Wrap-up Multi-modality application Available now on newer platforms or latest software upgrades Check with your vendor Little or no PACS/RIS software integration 3 – 5 year full roll out Direct IP to IP address connectivity Vendor software to generate spreadsheet reportsFuture Developments: Future DevelopmentseHealth: eHealth Combined with RDSR could be an answer for developing an individual dose record for PCEHR (personally controlled electronic health record) Need to start discussing with eHealth /NEHTA now for it to gain some traction on a busy and expanding agendaRadiation Oncology Imaging: Radiation Oncology Imaging Improved sophistication and accuracy of treatment beam delivery IMRT MLC Rotational Recognition of regional organ radiosensitivities Serial vs. parallel functioning Improved targeting requires a greater dependence on diagnostic imagingWhere’s The Throttle Point(s)?: Where’s The Throttle Point(s)? 49 Referrer Knowledge Radiologist as Gatekeeper Optimized AcquisitionARPANSA Preferred Outcomes: ARPANSA Preferred Outcomes 50The End: The End You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
2011 Victorian CTTG Monash jakey39 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 32 Category: Education License: All Rights Reserved Like it (0) Dislike it (0) Added: August 27, 2011 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript ARPANSA MDCT Updates: ARPANSA MDCT Updates Anthony Wallace, Manager, Diagnostic Imaging & Nuclear Medicine Section, ARPANSA anthony.wallace@arpansa.gov.auTopics: Topics National, State & Territory regulatory environment ARPANSA NDRL survey Clinically useful dosimetry Recent propositions from Brenner Effective Dose applied to individuals Organ dose development necessity Radiation Dose Structured Reports Future developments eHealth and individual dose histories Radiation Oncology imaging RDSR as a national dose survey toolAustralian Regulatory Environment: Australian Regulatory EnvironmentRadiation Codes & Safety Guides: Radiation Codes & Safety Guides 4 NDRP RPS 6 Medical Code RPS 14 Safety Guides 2008 RPS 14.1 2008 RPS 14.2 2008 RPS 14.3 2004 2008 http://www.arpansa.gov.au/Publications/codes/rps.cfmDirect & Indirect Regulatory Drivers: Direct & Indirect Regulatory Drivers 5 ARPANSA Code of Practice Local Regulatory Requirements Medicare Practice Accreditation (DIAS)Codes & Safety Guides - DRLs: Codes & Safety Guides - DRLs 6 Diagnostic reference levels 3.1.8 The Responsible Person must establish a program to ensure that radiation doses administered to a patient for diagnostic purposes are: ( a) periodically compared with diagnostic reference levels ( DRLs) for diagnostic procedures for which DRLs have been established in Australia; and ( b) if DRLs are consistently exceeded, reviewed to determine whether radiation protection has been optimized .ARPANSA NDRL Survey: ARPANSA NDRL SurveyThe Rationale: The Rationale We want the data per scanned habitus You want a practice report per protocol You can use the report to assist in dose optimization To achieve this; Each protocol should be specific Don’t mix multiple phases, contrast with non-contrast, etc Dose modulation is problematic, mAs is indicativeSlide 9: www.arpansa.gov.au NDRL LinkPractice Registrations.....so far: Practice Registrations.....so far State/Territory Number ACT 4 NSW 7 NT 0 QLD 3 SA 0 TAS 0 VIC 5 WA 9Clinically Useful Dosimetry: Clinically Useful DosimetryThe Old, Tried & True Standards: The Old, Tried & True Standards CTDI Air , Weighted, Volume (mGy) DLP (mGy.cm) mSv/mGy.cm conversion tables If you don’t know what these are and how they are applied to patient dosimetry You should be having a serious look at yourselfThe Effective Dose Dilemma: The Effective Dose Dilemma California has recently legislated as mandatory that all CT patients must be told the effective dose of the procedure and its consequent risk for them The fact that effective dose is a statistical population risk construct and cannot be applied to the individual didn’t seem to carry much weight A knee jerk response to CT dose sensitivity Don’t think it couldn’t happen hereIf Not Effective Dose……..?: If Not Effective Dose……..? Effective dose is an inappropriate dose risk metric for the individual More accurate radiation risk assessments should be constructed from an organ dose assessment Individual radiosensitivities – normal distribution? Individual organ dose radiosensitivities Heterogeneous dose distributions Need a real time, platform embedded organ dose calculator for reasonable risk assessmentAge Dependent Dosimetry Risk: Age Dependent Dosimetry Risk Hall, Pediatric Radiology, (2002) Vol.32Prof. David Brenner Postulates: Prof. David Brenner Postulates Supports the increased radiosensitivities of paediatrics, but Proposes that there is an inverse relationship between age at exposure and expression of detriment An outcome of Bystander effectsBystander Effect: Bystander EffectAge related Cancer Mortality: Age related Cancer Mortality Cancer incidence still primarily expressed in late middle age and older but if exposed at younger age there will be an increased expression of detriment from those exposuresRadiation Dose Structured Reports: Radiation Dose Structured ReportsRadiation Dose Structured Report: Radiation Dose Structured ReportRDSR – General Use: RDSR – General UseRDSR – General Use: RDSR – General UseRDSR – Key Measurements: RDSR – Key MeasurementsRDSR – More Details: RDSR – More DetailsRDSR – Creating Reports: RDSR – Creating ReportsRDSR – Applications I: RDSR – Applications IRDSR – Applications 2: RDSR – Applications 2RDSR - Wrap-up: RDSR - Wrap-up Multi-modality application Available now on newer platforms or latest software upgrades Check with your vendor Little or no PACS/RIS software integration 3 – 5 year full roll out Direct IP to IP address connectivity Vendor software to generate spreadsheet reportsFuture Developments: Future DevelopmentseHealth: eHealth Combined with RDSR could be an answer for developing an individual dose record for PCEHR (personally controlled electronic health record) Need to start discussing with eHealth /NEHTA now for it to gain some traction on a busy and expanding agendaRadiation Oncology Imaging: Radiation Oncology Imaging Improved sophistication and accuracy of treatment beam delivery IMRT MLC Rotational Recognition of regional organ radiosensitivities Serial vs. parallel functioning Improved targeting requires a greater dependence on diagnostic imagingWhere’s The Throttle Point(s)?: Where’s The Throttle Point(s)? 49 Referrer Knowledge Radiologist as Gatekeeper Optimized AcquisitionARPANSA Preferred Outcomes: ARPANSA Preferred Outcomes 50The End: The End